Years Active: 2025
Title: Antti Karlsson: Innovator in Oncogenic Fusion Identification
Introduction
Antti Karlsson is a notable inventor based in Parainen, Finland. He has made significant contributions to the field of oncology through his innovative work. His research focuses on identifying candidate signs indicative of NTRK oncogenic fusions, which are crucial for understanding certain types of cancer.
Latest Patents
Antti Karlsson holds a patent titled "Identification of candidate signs indicative of an NTRK oncogenic fusion." This invention relates to a computer-implemented method, a system, and a non-transitory computer-readable storage medium. It aims to determine a probability value from patient data, indicating the likelihood of a subject patient suffering from cancer caused by a mutation of the neurotrophic receptor tyrosine kinase (NTRK) gene. He has 1 patent to his name.
Career Highlights
Throughout his career, Karlsson has focused on the intersection of technology and healthcare. His work has the potential to improve cancer diagnosis and treatment, making a significant impact on patient outcomes.
Collaborations
Antti has collaborated with notable professionals in his field, including Arndt Schmitz and Eren Metin Elci. These partnerships have enhanced the quality and reach of his research.
Conclusion
Antti Karlsson is a pioneering inventor whose work in identifying oncogenic fusions is paving the way for advancements in cancer treatment. His contributions are vital to the ongoing fight against cancer, and his innovative spirit continues to inspire others in the field.